-
epidemiology, innovative sequencing and bioinformatics technologies including single cell and spatial transcriptomics, molecular biology approaches using cell-based and animal models, and biomarker studies from
-
relapse in order to design novel inhibitors to intervene the malignancies 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell sequencing chor high throughput proteomics 4
-
, molecular biology, biochemistry and cell biology, chemical biology, immunology, functional genomics, signal transduction, single-cell sequencing, spatial sequencing, metabolism, drug development, structural
-
cell transplantation models, mouse genetics, molecular biology, biochemistry and cell biology, chemical biology, immunology, functional genomics, signal transduction, single-cell sequencing, spatial
-
therapeutics or nucleic-acid chemistry o Nanoparticle / liposome formulation and characterization o HTS assay development and robotic screening o Recombinant protein expression in multiple hosts o
-
, FOLFOX-3B—all of which completed with numerous biomarker-driven projects pending). Participate in paper writing of multiple research projects. Data sets will be electronic. No biological samples will be
-
scientific rigor and excellence as documented by peer-reviewed publications. Ability to work in a fast-paced research environment and manage multiple projects and collaborations. Strong team player with
-
supported by multiple NIH award (R01, U54) and several other prestigious private awards. As a successful candidate, you will: Directly work on the following projects: 1) RNA modifications and RNA-binding
-
within the Institute emcompasses multiple disciplines relating to both diabetes and metabolism. As a successful candidate you will: · Perform a variety of wet lab experiments to test the roles
-
presentation, ability to work efficiently in a team and with collaborators · Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage · Previous